These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2575 related articles for article (PubMed ID: 15647825)
21. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. Herdick M; Carlberg C J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478 [TBL] [Abstract][Full Text] [Related]
23. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. Zou A; Elgort MG; Allegretto EA J Biol Chem; 1997 Jul; 272(30):19027-34. PubMed ID: 9228086 [TBL] [Abstract][Full Text] [Related]
24. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Kane KF; Langman MJ; Williams GR Cancer Res; 1996 Feb; 56(3):623-32. PubMed ID: 8564982 [TBL] [Abstract][Full Text] [Related]
26. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131 [TBL] [Abstract][Full Text] [Related]
27. Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells. Yang W; Hyllner SJ; Christakos S Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E162-70. PubMed ID: 11404234 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220 [TBL] [Abstract][Full Text] [Related]
29. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor. Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643 [TBL] [Abstract][Full Text] [Related]
30. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Peräkylä M; Malinen M; Herzig KH; Carlberg C Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. Meyer MB; Goetsch PD; Pike JW J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):136-41. PubMed ID: 20171278 [TBL] [Abstract][Full Text] [Related]
32. NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Kabe Y; Yamada J; Uga H; Yamaguchi Y; Wada T; Handa H Mol Cell Biol; 2005 Jan; 25(1):512-22. PubMed ID: 15601870 [TBL] [Abstract][Full Text] [Related]
33. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Imai Y; Pike JW; Koeffler HP Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077 [TBL] [Abstract][Full Text] [Related]
34. The impact of chromatin organization of vitamin D target genes. Carlberg C; Dunlop TW Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures. Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948 [TBL] [Abstract][Full Text] [Related]
36. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene. Wu Y; Craig TA; Lutz WH; Kumar R Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935 [TBL] [Abstract][Full Text] [Related]
37. The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor. Seoane S; Perez-Fernandez R Mol Endocrinol; 2006 Apr; 20(4):735-48. PubMed ID: 16322098 [TBL] [Abstract][Full Text] [Related]
38. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein. Raval-Pandya M; Dhawan P; Barletta F; Christakos S Mol Endocrinol; 2001 Jun; 15(6):1035-46. PubMed ID: 11376120 [TBL] [Abstract][Full Text] [Related]
39. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. Kephart DD; Walfish PG; DeLuca H; Butt TR Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985 [TBL] [Abstract][Full Text] [Related]
40. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1). Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]